PUBLISHER: The Business Research Company | PRODUCT CODE: 1945290
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945290
Hemostats and tissue sealants are products utilized during surgical procedures to manage bleeding (hemostasis) and seal tissues, thereby preventing the leakage of fluids like blood or air. Hemostats function by either encouraging clot formation or physically clamping blood vessels to halt bleeding, while tissue sealants are used to close wounds or surgical cuts, supporting quicker healing and lowering the likelihood of complications.
The primary categories of hemostats and tissue sealants include topical hemostats, adhesives and tissue sealants, fibrin sealants, and others. Topical hemostats are substances or materials directly applied to bleeding areas to control bleeding during surgeries or traumatic injuries. These are formulated from biological-based, synthetic-based, or combined materials, and are distributed through various channels such as direct sales, distributors, and online platforms. Their applications span across surgical procedures, trauma care, cardiovascular and general surgeries, among others, and they serve multiple end users including hospitals, ambulatory surgical centers (ASCs), specialty clinics, and academic and research institutions.
Tariffs are impacting the hemostats and tissue sealants market by increasing costs of imported biological and synthetic raw materials used in product manufacturing. Segments such as fibrin sealants and combination hemostats are most impacted, with Asia-Pacific regions like China and India facing significant import duties. This has led to higher production costs and supply chain delays. Positively, tariffs have driven local manufacturing initiatives, encouraged material innovation, and promoted investment in domestic production capabilities.
The hemostats and tissue sealants market research report is one of a series of new reports from The Business Research Company that provides hemostats and tissue sealants market statistics, including hemostats and tissue sealants industry global market size, regional shares, competitors with a hemostats and tissue sealants market share, detailed hemostats and tissue sealants market segments, market trends and opportunities, and any further data you may need to thrive in the hemostats and tissue sealants industry. This hemostats and tissue sealants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The hemostats and tissue sealants market size has grown strongly in recent years. It will grow from $4.35 billion in 2025 to $4.64 billion in 2026 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to reliance on traditional mechanical hemostats, limited availability of synthetic sealants, increasing surgical procedures, growing hospital infrastructure, early adoption of fibrin-based sealants.
The hemostats and tissue sealants market size is expected to see strong growth in the next few years. It will grow to $5.97 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to development of next-generation tissue adhesives, rising minimally invasive surgeries, growing cardiovascular and trauma surgeries, increased research in hemostasis technologies, expansion of direct and online distribution channels. Major trends in the forecast period include rising adoption of advanced hemostatic products, increased use of synthetic and combination sealants, expansion of cardiovascular and trauma surgeries, focus on minimally invasive and faster recovery procedures, growing research and academic applications in hemostasis.
The growing number of surgical procedures is expected to drive the expansion of the hemostats and tissue sealants market. Surgical procedures involve manual and instrumental techniques performed by surgeons to diagnose, treat, or remove diseased tissues or organs, or to restore bodily functions. The increase in these procedures is largely attributed to the rising prevalence of chronic diseases, which frequently require surgical intervention for proper management, treatment, or to prevent complications. Hemostats and tissue sealants play a crucial role in these procedures by effectively controlling bleeding and sealing tissues, thereby minimizing complications and enhancing surgical outcomes. For example, in June 2024, the International Society of Aesthetic Plastic Surgery (ISAPS), a U.S.-based professional organization for board-certified aesthetic plastic surgeons, reported a 5.5% increase in surgical procedures in 2023, with over 15.8 million surgeries and 19.1 million non-surgical procedures conducted worldwide. This trend underscores how the increasing number of surgical procedures is fueling the demand for hemostats and tissue sealants.
Leading companies in the hemostats and tissue sealants market are prioritizing the development of innovative products, such as ready-to-use absorbable collagen pads, to enhance the effectiveness and efficiency of surgical care. These collagen-based hemostats are designed using bioactive, resorbable materials that require no preparation, offering immediate application for effective tissue sealing and hemostasis. In April 2025, Baxter International Inc., a U.S.-based healthcare company, introduced the Hemopatch Sealing Hemostat at a symposium in Austria. This new product is designed for room temperature storage and offers the convenience of being ready-to-use without the need for pre-warming. It is suitable for both open and minimally invasive surgeries and eliminates the need for refrigeration or additional preparation. The Hemopatch's strong adhesive capabilities, extended shelf life, and rapid hemostatic response enable more efficient bleeding and leakage control during surgery, contributing to improved surgical precision and better patient recovery outcomes across various specialties.
In March 2024, Advanced Medical Solutions Group PLC, a UK-based medical technology company, acquired Peters Surgical SAS for $154.6 million. This acquisition is aimed at expanding Advanced Medical Solutions' surgical product portfolio, reinforcing its footprint in key European markets, and enhancing its position in the global wound care and closure technologies sector. Peters Surgical SAS, based in France, specializes in producing medical devices and instruments focused on hemostats and tissue sealants.
Major companies operating in the hemostats and tissue sealants market are Johnson & Johnson, Medtronic plc, Becton Dickinson and Company (BD), Stryker Corporation, Baxter International Inc., Meril Life Sciences Pvt. Ltd., Teleflex Incorporated, Integra LifeSciences Holdings Corporation, Corza Medical Inc., Artivion Inc., Ethicon Inc., Advanced Medical Solutions Group plc, Marine Polymer Technologies Inc., Samyang Holdings Corporation, 3-D Matrix Medical Technology Co Ltd., GELITA AG, BioCer Entwicklungs-GmbH, AEGIS Lifesciences Pvt. Ltd., Betatech Medical Ltd., Cohera Medical Inc.
North America was the largest region in the hemostats and tissue sealants market in 2025. The regions covered in the hemostats and tissue sealants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the hemostats and tissue sealants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The hemostats and tissue sealants market consists of sales of gelatin-based hemostats, fibrin sealants, oxidized regenerated cellulose, thrombin-based hemostats, and cyanoacrylate-based tissue adhesives. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Hemostats And Tissue Sealants Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses hemostats and tissue sealants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for hemostats and tissue sealants ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hemostats and tissue sealants market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.